Morgan Stanley
CRBU icon

Morgan Stanley’s Caribou Biosciences CRBU Stock Holding History

Morgan Stanley’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Sell
121,320
-123,792
-51% -$245K ﹤0.01% 5927
2026
Q1 		$466K Sell
245,112
-53,344
-18% -$91.6K ﹤0.01% 5521
2025
Q4 		$475K Sell
298,456
-59,763
-17% -$125K ﹤0.01% 5547
2025
Q3 		$835K Buy
358,219
+26,738
+8% +$50.5K ﹤0.01% 5256
2025
Q2 		$418K Sell
331,481
-151,283
-31% -$149K ﹤0.01% 5545
2025
Q1 		$441K Sell
482,764
-2,266,833
-82% -$2.95M ﹤0.01% 5384
2024
Q4 		$4.37M Buy
2,749,597
+1,551,432
+129% +$3.12M ﹤0.01% 4110
2024
Q3 		$2.35M Buy
1,198,165
+579,678
+94% +$1.19M ﹤0.01% 4531
2024
Q2 		$1.01M Buy
618,487
+203,990
+49% +$652K ﹤0.01% 4950
2024
Q1 		$2.13M Sell
414,497
-690,316
-62% -$4.26M ﹤0.01% 4534
2023
Q4 		$6.33M Sell
1,104,813
-712,866
-39% -$3.52M ﹤0.01% 3729
2023
Q3 		$8.69M Buy
1,817,679
+550,946
+43% +$3.42M ﹤0.01% 3253
2023
Q2 		$5.38M Buy
1,266,733
+17,485
+1% +$78.6K ﹤0.01% 3713
2023
Q1 		$6.63M Buy
1,249,248
+20,081
+2% +$125K ﹤0.01% 3537
2022
Q4 		$7.72M Buy
1,229,167
+14,575
+1% +$130K ﹤0.01% 3326
2022
Q3 		$12.8M Buy
1,214,592
+571,409
+89% +$5.32M ﹤0.01% 2691
2022
Q2 		$3.49M Buy
643,183
+440,295
+217% +$3.37M ﹤0.01% 4080
2022
Q1 		$1.86M Buy
202,888
+99,820
+97% +$1.05M ﹤0.01% 4564
2021
Q4 		$1.56M Buy
103,068
+50,312
+95% +$978K ﹤0.01% 4763
2021
Q3 		$1.26M Buy
+52,756
New +$1.29M ﹤0.01% 4893

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley's CRBU Position: Q2 2026 in Review

Morgan Stanley reduced its Caribou Biosciences (CRBU) stake by 51% in Q2 2026, selling an estimated $245K and leaving 121,320 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #5927.

Morgan Stanley first reported a position in CRBU in Q3 2021 and has held it in 20 quarters since. The position peaked at $12.8M in Q3 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Morgan Stanley held 121,320 shares of Caribou Biosciences worth $214K as of Q2 2026.
  • Morgan Stanley sold 123,792 Caribou Biosciences shares in Q2 2026, an estimated $245K.
  • Caribou Biosciences made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5927 holding.
  • Morgan Stanley first reported a position in Caribou Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Morgan Stanley's Caribou Biosciences position peaked at $12.8M in Q3 2022.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.